Synergism between genomic and non genomic estrogen action mechanisms

被引:25
作者
Accocia, F [1 ]
Marino, M [1 ]
机构
[1] Univ Roma Tre, Dept Biol, I-00146 Rome, Italy
关键词
17; beta-estradiol; signal transduction pathways; non genomic action; gene transcription; HepG2; cells;
D O I
10.1080/1521654031000110172
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 17beta-estradiol (E2) action mechanism for inducing target gene expression can be attributed to both the direct binding of its receptor (ER) to specific sequences, the estrogen response element (ERE), and to the interaction between ER and other DNA-binding transcription factors. At the present meagre information is available for the role played by the rapid hormone action mechanism(s) (i.e., activation of ERK, PI(3) K, PKC-alpha) in modulating E2-induced gene promoter activity. Here the involvement of the rapid non genomic mechanism in triggering the transcriptional activity of two E2-regulated target genes in human hepatoma HepG2 cells has been studied, taking into consideration the cyclin D1 (ERE-devoid) and the complement protein 3 (ERE-containing) promoter-luciferase report constructs. The results indicate that the activation of the ERK pathway is essential for the E2-induced activity of both promoters, whereas the other rapid E2-induced membrane-starting signal transduction pathways (i.e., PI(3) K and PKC-alpha) were differently required. These results permit the amplification of the E2 action mechanism by the addition of synergy between the non genomic and genomic molecular actions of the E2-induced gene transcription.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 30 条
[1]  
ARCHER TK, 1985, J BIOL CHEM, V260, P1676
[2]  
ARCHER TK, 1986, J BIOL CHEM, V261, P5067
[3]   Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions [J].
Björnström, L ;
Sjöberg, M .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (10) :2202-2214
[4]   Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α -: A new model for anti-estrogen resistance [J].
Campbell, RA ;
Bhat-Nakshatri, P ;
Patel, NM ;
Constantinidou, D ;
Ali, S ;
Nakshatri, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) :9817-9824
[5]   PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells [J].
Castoria, G ;
Migliaccio, A ;
Bilancio, A ;
Di Domenico, M ;
de Falco, A ;
Lombardi, M ;
Fiorentino, R ;
Varricchio, L ;
Barone, MV ;
Auricchio, F .
EMBO JOURNAL, 2001, 20 (21) :6050-6059
[6]   Increased mitochondrial superoxide production in rat liver mitochondria, rat hepatocytes, and HepG2 cells following ethinyl estradiol treatment [J].
Chen, JQ ;
Li, YB ;
Lavigne, JA ;
Trush, HA ;
Yager, JD .
TOXICOLOGICAL SCIENCES, 1999, 51 (02) :224-235
[7]   Intracellular signaling pathways: Nongenomic actions of estrogens and ligand-independent activation of estrogen receptors [J].
Coleman, KM ;
Smith, CL .
FRONTIERS IN BIOSCIENCE, 2001, 6 :D1379-D1391
[8]   Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells [J].
Duan, RQ ;
Xie, W ;
Li, XR ;
McDougal, A ;
Safe, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 294 (02) :384-394
[9]   Orphan receptor hepatocyte nuclear factor-4 antagonizes estrogen receptor α-mediated induction of human coagulation factor XII gene [J].
Farsetti, A ;
Moretti, F ;
Narducci, M ;
Misiti, S ;
Nanni, S ;
Andreoli, M ;
Sacchi, A ;
Pontecorvi, A .
ENDOCRINOLOGY, 1998, 139 (11) :4581-4589
[10]   Estrogens and cell-cycle regulation in breast cancer [J].
Foster, JS ;
Henley, DC ;
Ahamed, S ;
Wimalasena, J .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (07) :320-327